Baillie Gifford & CO Pacira Bio Sciences, Inc. Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$25.5 - $31.51 $4.96 Million - $6.13 Million	-194,677 Reduced 19.45%	806,097 $23.1 Million
Q1 2024 May 01, 2024	SELL	$27.7 - $35.48 $1.73 Million - $2.22 Million	-62,492 Reduced 5.88%	1,000,774 $29.2 Million
Q4 2023 Jan 26, 2024	SELL	$26.32 - $34.31 $15.1 Million - $19.7 Million	-573,810 Reduced 35.05%	1,063,266 $35.9 Million
Q3 2023 Nov 13, 2023	SELL	$30.68 - $40.09 $659,221 - $861,413	-21,487 Reduced 1.3%	1,637,076 $50.2 Million
Q2 2023 Jul 28, 2023	SELL	$36.12 - $47.5 $8.39 Million - $11 Million	-232,278 Reduced 12.28%	1,658,563 $66.5 Million
Q1 2023 May 03, 2023	BUY	$35.53 - $43.38 $856,273 - $1.05 Million	24,100 Added 1.29%	1,890,841 $77.2 Million
Q4 2022 Jan 24, 2023	BUY	$38.19 - $57.45 $723,471 - $1.09 Million	18,944 Added 1.03%	1,866,741 $72.1 Million
Q3 2022 Oct 27, 2022	SELL	$51.24 - $58.89 $4.46 Million - $5.12 Million	-86,955 Reduced 4.49%	1,847,797 $98.3 Million
Q2 2022 Aug 08, 2022	SELL	$51.49 - $81.64 $9.52 Million - $15.1 Million	-184,848 Reduced 8.72%	1,934,752 $113 Million
Q1 2022 May 05, 2022	SELL	$60.03 - $76.49 $14.1 Million - $18 Million	-235,640 Reduced 10.0%	2,119,600 $162 Million
Q4 2021 Jan 20, 2022	BUY	$47.97 - $62.21 $12.8 Million - $16.6 Million	267,433 Added 12.81%	2,355,240 $142 Million
Q3 2021 Oct 19, 2021	SELL	$54.64 - $61.3 $816,977 - $916,557	-14,952 Reduced 0.71%	2,087,807 $117 Million
Q2 2021 Aug 02, 2021	BUY	$59.18 - $69.99 $430,712 - $509,387	7,278 Added 0.35%	2,102,759 $128 Million
Q1 2021 May 06, 2021	BUY	$59.31 - $78.82 $7.81 Million - $10.4 Million	131,686 Added 6.71%	2,095,481 $147 Million
Q4 2020 Feb 10, 2021	BUY	$50.47 - $66.26 $10.3 Million - $13.6 Million	204,806 Added 11.64%	1,963,795 $118 Million
Q3 2020 Nov 12, 2020	BUY	$51.97 - $63.0 $15.6 Million - $18.9 Million	299,363 Added 20.51%	1,758,989 $106 Million
Q2 2020 Aug 12, 2020	BUY	$30.8 - $52.47 $1.47 Million - $2.5 Million	47,734 Added 3.38%	1,459,626 $76.6 Million
Q1 2020 May 08, 2020	BUY	$28.4 - $50.7 $694,294 - $1.24 Million	24,447 Added 1.76%	1,411,892 $47.3 Million
Q4 2019 Feb 10, 2020	BUY	$36.31 - $46.83 $8.56 Million - $11 Million	235,735 Added 20.47%	1,387,445 $62.9 Million
Q3 2019 Nov 07, 2019	BUY	$35.66 - $44.99 $5.59 Million - $7.06 Million	156,871 Added 15.77%	1,151,710 $43.8 Million
Q2 2019 Aug 08, 2019	BUY	$36.57 - $47.97 $143,756 - $188,570	3,931 Added 0.4%	994,839 $43.3 Million
Q1 2019 May 01, 2019	BUY	$36.47 - $42.17 $2.09 Million - $2.42 Million	57,367 Added 6.15%	990,908 $0
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $5.43 Million - $6.86 Million	131,532 Added 16.4%	933,541 $40.2 Million
Q3 2018 Nov 13, 2018	BUY	$32.85 - $52.0 $7.23 Million - $11.4 Million	220,009 Added 37.8%	802,009 $39.4 Million
Q2 2018 Jul 17, 2018	BUY	$27.5 - $39.8 $1.98 Million - $2.86 Million	71,903 Added 14.1%	582,000 $18.7 Million
Q1 2018 May 10, 2018	BUY	$29.98 - $46.35 $4.2 Million - $6.49 Million	139,935 Added 37.8%	510,097 $15.9 Million
Q4 2017 Feb 13, 2018	BUY	$31.85 - $46.95 $1.58 Million - $2.33 Million	49,580 Added 15.47%	370,162 $16.9 Million
Q3 2017 Oct 20, 2017	BUY	$35.7 - $39.5 $699,077 - $773,489	19,582 Added 6.51%	320,582 $12 Million
Q2 2017 Aug 10, 2017	BUY	N/A	301,000	301,000 $14.4 Million

Others Institutions Holding PCRX

# of Institutions

266

Shares Held

50.6M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$133 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$88 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$82.4 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$33.4 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$32.9 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $761M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account